Timing of Surgery Following Preoperative Therapy in Rectal Cancer: The Need for a Prospective Randomized Trial?

被引:51
作者
Evans, Jessica [1 ,2 ,3 ]
Tait, Diana [4 ]
Swift, Ian [3 ]
Pennert, Kjell [5 ]
Tekkis, Paris [1 ]
Wotherspoon, Andrew [6 ]
Chau, Ian [7 ]
Cunningham, David [7 ]
Brown, Gina [2 ]
机构
[1] Royal Marsden Hosp, Dept Surg, London SW3 6JJ, England
[2] Royal Marsden Hosp, Dept Radiol, London SW3 6JJ, England
[3] Mayday Univ Hosp, Dept Surg & Radiol, Croydon, England
[4] Royal Marsden Hosp, Dept Clin Oncol, London SW3 6JJ, England
[5] Royal Marsden Hosp, Dept Stat, London SW3 6JJ, England
[6] Royal Marsden Hosp, Dept Pathol, London SW3 6JJ, England
[7] Royal Marsden Hosp, Dept Med Oncol, London SW3 6JJ, England
关键词
Rectal cancer; Chemoradiotherapy; Timing of surgery; Tumor downstaging; PATHOLOGICAL COMPLETE RESPONSE; NEOADJUVANT CHEMORADIOTHERAPY; CIRCUMFERENTIAL MARGIN; PROGNOSTIC VALUE; III TRIAL; CHEMORADIATION; REGIMENS; INTERVAL;
D O I
10.1097/DCR.0b013e3182281f4b
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: In rectal cancer, the standard of care after the completion of radiotherapy is surgery at 6 to 8 weeks. However, there is variation regarding the timing of surgery. OBJECTIVE: This investigation aimed to audit the timing of surgery following radiotherapy and to compare perioperative morbidity and tumor downstaging in patients operated on, before and after the 6- to 8-week window. DESIGN: A retrospective review of rectal cancers treated preoperatively in our cancer network over a 27-month period. The effect of "time till surgery" of 6 to 8 weeks, <6 weeks, and >8 weeks on T downstaging and nodal downstaging was calculated by univariate and multivariate logistic regression analyses. SETTING: This study was conducted in an oncology tertiary referral center in the Southwest London Cancer Network. PATIENTS: Patients receiving preoperative radiotherapy for primary locally advanced rectal cancer undergoing subsequent surgical resection were eligible. MAIN OUTCOME MEASURES: The primary outcome measurement was time to surgery following the completion of (chemo) radiotherapy. Thirty-day perioperative morbidity and mortality and tumor and nodal downstaging were examined according to the timing of surgery. LIMITATIONS: This study was limited by its nonrandomized retrospective design and the lack of standardization of preoperative chemotherapy. RESULTS: Thirty-two (34%) patients underwent surgery at 6 to 8 weeks, 45 (47%) at >8 weeks, and 18 (19%) at <6 weeks after radiotherapy. Delay was attributed to scheduling in 87% of cases and to comorbidities in the remainder. T downstaging occurred in 6 (33.3%) patients in the <6 weeks group, in 12 (37.5%) in the 6 to 8 weeks group, and in 28 (62.2%) in >8 weeks group with no significant differences in perioperative morbidity. On multivariate analysis, T downstaging was significantly greater for the >8 weeks group (OR, 3.79; 95% CI: 1.11-12.99; P = .03). More patients were staged ypT0-T2, 19 of 45 (42%) in the >8 weeks group vs other groups, 14 of 50 (28%, P < .05). CONCLUSIONS: Following radiotherapy, surgery frequently occurs at >8 weeks and is associated with increased downstaging. The consequences on survival and perioperative morbidity warrant further investigation.
引用
收藏
页码:1251 / 1259
页数:9
相关论文
共 23 条
[1]   The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy [J].
Beresford, M ;
Glynne-Jones, R ;
Richman, P ;
Makris, A ;
Mawdsley, S ;
Stott, D ;
Harrison, M ;
Osborne, M ;
Ashford, R ;
Grainger, J ;
Al-Jabbour, J ;
Talbot, I ;
Mitchell, IC ;
Thomas, JM ;
Livingstone, JI ;
McCue, J ;
MacDonald, P ;
Northover, JAM ;
Windsor, A ;
Novell, R ;
Wallace, M ;
Harrison, RA .
CLINICAL ONCOLOGY, 2005, 17 (06) :448-455
[2]   Circumferential resection margin as a prognostic factor in rectal cancer [J].
Bernstein, T. E. ;
Endreseth, B. H. ;
Romundstad, P. ;
Wibe, A. .
BRITISH JOURNAL OF SURGERY, 2009, 96 (11) :1348-1357
[3]   Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study [J].
Brown, G. ;
Daniels, I. R. ;
Heald, R. J. ;
Quirke, P. ;
Blomqvist, L. ;
Sebag-Montefiore, D. ;
Moran, B. J. ;
Holm, T. ;
Strassbourg, J. ;
Peppercorn, P. D. ;
Fisher, S. E. ;
Mason, B. .
BRITISH MEDICAL JOURNAL, 2006, 333 (7572) :779-782
[4]   Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer [J].
Brown, G ;
Daniels, IR ;
Richardson, C ;
Revell, P ;
Peppercorn, D ;
Bourne, M .
BRITISH JOURNAL OF RADIOLOGY, 2005, 78 (927) :245-251
[5]   Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging [J].
Brown, G ;
Radcliffe, AG ;
Newcombe, RG ;
Dallimore, NS ;
Bourne, MW ;
Williams, GT .
BRITISH JOURNAL OF SURGERY, 2003, 90 (03) :355-364
[6]   Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypcr patients [J].
Capirci, Carlo ;
Valentini, Vincenzo ;
Cionini, Luca ;
De Paoli, Antonino ;
Rodel, Claus ;
Glynne-Jones, Robert ;
Coco, Claudio ;
Romano, Mario ;
Mantello, Giovanna ;
Palazzi, Silvia ;
Mattia, Falchetti Osti ;
Friso, Maria Luisa ;
Genovesi, Domenico ;
Vidali, Cristiana ;
Gambacorta, Maria Antonietta ;
Buffoli, Alberto ;
Lupattelli, Marco ;
Favretto, Maria Silvia ;
La Torre, Giuseppe .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01) :99-107
[7]   Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer [J].
Chan, I ;
Brown, G ;
Cunningham, D ;
Tait, D ;
Wotherspoon, A ;
Norman, AR ;
Tebbutt, N ;
Hill, M ;
Ross, PJ ;
Massey, A ;
Oates, J .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) :668-674
[8]   Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial [J].
Francois, Y ;
Nemoz, CJ ;
Baulieux, J ;
Vignal, J ;
Grandjean, JP ;
Partensky, C ;
Souquet, JC ;
Adeleine, P ;
Gerard, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2396-2402
[9]   Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2 [J].
Gerard, Jean-Pierre ;
Azria, David ;
Gourgou-Bourgade, Sophie ;
Martel-Laffay, Isabelle ;
Hennequin, Christophe ;
Etienne, Pierre-Luc ;
Vendrely, Veronique ;
Francois, Eric ;
de La Roche, Guy ;
Bouche, Olivier ;
Mirabel, Xavier ;
Denis, Bernard ;
Mineur, Laurent ;
Berdah, Jean-Francois ;
Mahe, Marc Andre ;
Becouarn, Yves ;
Dupuis, Olivier ;
Lledo, Gerard ;
Montoto-Grillot, Christine ;
Conroy, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) :1638-1644
[10]   Cetuximab and chemoradiation for rectal cancer-is the water getting muddy? [J].
Glynne-Jones, Rob ;
Mawdsley, Suzy ;
Harrison, Mark .
ACTA ONCOLOGICA, 2010, 49 (03) :278-286